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INSIGHTS FROM MODEL SYSTEMS
Molecular Prophets of Death in the Fly
Antony Rodriguez, Po Chen, and John M. Abrams
Department of Cell Biology and Neuroscience, University of Texas, Southwestern Medical Center, Dallas
During normal development and aging, tremendous
numbers of cells are systematically eliminated by a pro-
cess referred to as “programmed cell death” (PCD), or
apoptosis. This predictable loss of cells serves many di-
verse functions and has been most extensively studied
during morphogenesis, neurogenesis, and maturation of
the immune system (reviewed in Jacobson et al. 1997).
Usually triggered by systemic hormones, withdrawal of
trophic factors, or local cell interactions, apoptotic death
is an active choice of fate that requires autonomous ge-
netic functions within the dying cell. Apoptotic cells pro-
ceed through a series of changes characterized by
membrane blebbing, condensation of nuclear material,
cleavage of DNA into nucleosomal size fragments, and
fragmentation into “corpses” that are rapidly engulfed
by macrophages (Jacobson et al. 1997). The widespread
occurrence of this stereotypical form of cell death among
vertebrate and invertebrate models, together with more
recent genetic evidence, indicates that the central mo-
lecular components required for this process are very
highly conserved.
A growing body of evidence has begun to clarify the
importance of PCD, both during normal development
and in human disease. Deletion of interdigital areas and
degeneration of neurons are good examples of cell pop-
ulations eliminated by apoptosis in development (Ja-
cobson et al. 1997). In human disease, misregulated
apoptosis constitutes an important mechanism under-
lying autoimmunities (Rieux et al. 1995), myelomas
(Landoweki et al. 1997), and lymphomas (Ashwell et al.
1994). It is also well established that viral infections
frequently elicit apoptotic responses in the host cell that
are blocked, directly or indirectly, by virally encoded
genes (White 1993). Finally, inappropriate cell death
may also account for the pathophysiology associated
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with degenerative diseases of the nervous system (re-
viewed in Bredesen 1995) and retina (see Travis 1998
[in this issue]).
The earliest genetic evidence that cells actively partic-
ipate in their own deaths came from work in the nem-
atode Caenorhabditis elegans, in which mutations pro-
vided the first indisputable evidence that apoptosis was
indeed a gene-directed process. Loss-of-function muta-
tions were found that prevented all cell deaths (Ellis and
Horvitz 1986). The cloning of genes corresponding to
several of these mutations has provided molecular entry
points into at least three essential components of a single
apoptotic pathway in this model. The nematode ced-9
gene and its human counterpart, BCL2, normally fun-
tion to suppress PCD (Hengartner and Horvitz 1994).
Another nematode gene, ced-3, is the founding member
of a growing family of cysteine proteases (Yuan et al.
1993), or caspases, that play essential roles during apop-
totic cell death. Cascades of caspase activity (Cohen
1997) cleave a number of substrates in association with
apoptotic death, and, although functional roles for many
substrates remain obscure, Enari et al (1998) have re-
cently identified a caspase-activated DNase responsible
for the characteristic degradation of chromosomal DNA
during apoptosis. A third nematode locus, ced-4, links
activities of upstream ced-9/BCL2 family members to
downstream caspases (Chinnaiyan et al. 1997; Spector
et al. 1997; Wu et al. 1997), and a human ced-4 coun-
terpart has been identified as well (Zou et al. 1997).
The H99 Genomic Region Is Required for Embryonic
Apoptosis in the Fly
A screen for cell death–defective mutations uncovered
a 300-kb genomic interval (the H99 region) required for
all apoptotic cell deaths during Drosophila embryonic
development (see sidebar). Although PCD fails to occur
in H99 deficiency strains, embryonic development pro-
ceeds rather normally. Ultimately, however, these ani-
mals accumulate vast excesses of cells, particularly in the
CNS (White et al. 1994). Damage-inducible apoptosis
is also profoundly defective in H99 homozygotes, sug-
gesting that common elements function in both normal
and pathological cell death.
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Courting death: Using synthetic deletions to
define death genes in the fly
The Drosophila embryo has proved to be an ideal system for
studying the genetic and molecular basis of development. Mu-
tant strains are readily obtained, and divergence from normal
developmental processes can be easily recognized with an ex-
tensive collection of cell type–specific markers, antibodies, and
reporter genes. Some of the most powerful features of this
model derive from the existence of well-characterized stocks,
bearing gross chromosomal alterations such as deletions, du-
plications, or translocations. These altered chromosomes typ-
ically carry visible “marker” genes (affecting eye morphology
or body color, for example), making it straightforward to iden-
tify flies with the desired alteration. The set of available “de-
ficiencies” covers about half of the Drosophila genome, and,
traditionally, these strains were tools to expedite complemen-
tation analysis and map new mutations. More recently, these
strains have facilitated a merging of genetic and physical maps
of the fly genome; for many of the strains, deletion breakpoints
have been reconciled with a physical map derived originally
from polytene chromosome banding patterns. Still more ana-
lytic power comes from cross breeding these altered strains to
create, for example, “synthetic deletions,” animals with two
distinct, but overlapping, chromosomal deletions. This ap-
proach allows the rapid definition of a minimal genomic interval
that is implicated in a given phenotype. We have exploited these
same tools to tease apart the separate roles of several related
and tightly linked genes in a gene complex needed for PCD.
We initially used acridine orange staining to detect abnormal
patterns of PCD in a set of chromosomal deletion strains. Panel
A shows the pattern of cell death in a wild-type embryo. Panel
B shows the complete loss of PCD in an embryo identified from
our screen; the deficiency in this homozygous mutant includes
a region, H99, which is required for all embryonic PCD (White
et al. 1994). When we created trans-heterozygous embryos,
carrying deletions that break within H99, we noted a partial
loss of PCD. Intermediate cell death–defective phenotypes, ob-
served in a series of synthetic deletions, suggested an additive
effect of multiple cell-death genes that all mapped to the H99,
a supposition that was confirmed with the cloning of three
related, and partially redundant, genes, reaper, grim, and hid.
When grim alone is restored to an embryo that carries the
homozygous H99 deletion (as in panel C), the defect in PCD
is intermediate between the wild-type and H99 phenotypes.
Activators of Cell Death in the H99 Chromosomal
Region
Three cell-death genes have been found in the H99
chromosomal interval, all of which are transcribed in
the same orientation, have a common motif at their N-
terminus, and appear to encode partially redundant
functions.
reaper
reaper, the first cell-death gene identified in the H99
interval, encodes a 65–amino acid cytoplasmic protein
bearing no obvious similarities to known proteins. This
gene product is selectively expressed in cells that will
later die (White et al. 1994), and its expression is suf-
ficient to trigger apoptosis in both transgenic (Hay et al.
1995; White et al. 1996) and cultured cells (Chen et al.
1996a; Pronk et al. 1996). Alignments between reaper
and the death domain of tumor necrosis factor receptor
1 (TNFR1) family members have led to suggestions that
these proteins might share an ancestral function (Gol-
stein et al. 1995). However, empirical tests have, so far,
failed to obtain evidence for a function shared by reaper
and the TNFR1 death domain (Chen et al. 1996a; Vucic
et al. 1997b).
As in mammalian tissues, ionizing radiation triggers
ectopic apoptosis in Drosophila. In mammals, p53 is a
central mediator of ionizing radiation–induced apop-
tosis (reviewed Canman et al. 1994), and, although no
Drosophila p53 homologue has yet been identified, the
similar reaction to irradiation suggests the presence of
an analogous pathway. It is also of interest to note that
reaper plays a role in apoptosis induced by ionizing ra-
diation and in other contexts of aberrant development.
Irradiation of fly embryos prior to the stage at which
PCDs first appear results in massive apoptosis (Abrams
et al. 1993), preceded by a striking induction of reaper
(Nordstrom et al. 1996). Similar inductive responses are
also seen in congenital mutants in which aberrant de-
velopment leads to massive apoptosis among cells that
would otherwise survive (Nordstrom et al. 1996). These
observations, together with studies on the behavior of
reporter transgenes, establish that reaper mRNA be-
haves as a transcriptional “prophet of death” when cells
are provoked to die by “unnatural causes. Recently,
reaper has also been shown to induce apoptosis in Xen-
opus (Evans et al. 1997), and this finding fuels specu-
lation concerning the existence of vertebrate reaper
homologues.
grim
As the physical map of the reaper region was com-
piled, evidence suggesting that the H99 interval might
harbor more than a single cell-death gene began to
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Figure 1 Manipulation of tissue by engaging elements of the apoptotic machine. Selective expression of an apoptotic activator, grim, in
the developing fly retina provokes massive cell death and deletion of this tissue. Compare wild-type eye (A) and ablated eye of the pGMRgrim
strain (B). These deaths are completely prevented (C) by coexpression of p35, a viral antiapoptotic protein that inhibits caspase action. The
result (C) demonstrates that preservation of apoptotic tissues may be achieved through targets of caspase function. (These panels are reprinted
here from the article by Chen et al. [1996b, p. 1773], with the permission of Genes & Development and the Cold Spring Harbor Laboratory
Press.)
emerge (see sidebar). The most definitive observation in
this regard was that fly strains bearing deletions internal
to the H99 breakpoints displayed markedly less severe
phenotypes when placed in trans to the H99 deletion.
This complexity could be explained by presuming that
at least one, or possibly two, additional cell-death func-
tions map to this region. Direct tests for such a function
led to the identification of grim (Chen et al. 1996b), a
cell-death gene that exhibits many features in common
with reaper.
The deduced open reading frame for grim is a protein
of 138 amino acids with no predicted transmembrane
domains and no extensive homologies to any sequence
in the current GenBank database (http://www.ncbi
.nlm.nih.gov/BLAST). The amino terminal end of grim
shares notable similarity to reaper, but reaper (Chen et
al. 1996b) and grim (P. Chen and J. M. Abrams, un-
published data) mutants deleted for these residues are
still able to provoke apoptosis in cell-culture assays (al-
beit with less potency). The shared N-terminal motif is
therefore not absolutely essential for killing but may
confer functions associated with protein stability and/or
regulation.
Several lines of evidence established that grim encodes
an activator of PCD during development. First, germ-
line transformation of genomic DNA spanning the grim
locus resulted in partial restoration of cell death to H99
mutant embryos. Also, induction of grim in either cul-
tured cells or ectopic tissues triggered extensive apop-
tosis, and these deaths were prevented by p35, a viral
anti-apoptosis protein that targets essential components
of the death machinery (fig. 1). Finally, expression of
grim selectively anticipates PCD during embryonic de-
velopment (Chen et al. 1996b) and in metamorphosis
(Robinow et al. 1997). These observations suggest that,
like reaper, grim is both a prophet of death and an ac-
tivator of apoptosis.
Head Involution Defective (hid)
The hid gene was originally described as a locus re-
quired for proper head and genitalia formation (Abbott
and Lengyel 1991). Embryos carrying single-gene hid
mutations do not exhibit gross cell-death defects that
phenocopy the H99 deletion, but they do manifest par-
tial failures in apoptosis (Grether et al. 1995). The in-
cidence of PCD is noticeably reduced in these mutants,
and supernumerary cells are observed in the larval optic
nerve. It is also clear that expression of hid is sufficient
to trigger extensive apoptosis in both transgenic animals
(Grether et al. 1995) and cell culture (J. Varkey and J.
M. Abrams, unpublished data). Also, like the previous
models described for reaper and grim, these deaths are
also prevented by coexpression of p35. The predicted
hid gene product is a novel 410–amino acid protein rich
in serine and proline residues. Although hid mRNA oc-
curs in many regions that are coincident with patterns
of PCD, it does not behave like a prophet of death,
because expression of this gene occurs in many cells that
do not ultimately die.
How do reaper, grim, and hid function to elicit apop-
tosis? Investigating this question is certain to be a high
priority for the future, yet already several observations
permit us to make some predictions in this regard. First,
conditional expression studies show that each gene is
sufficient to elicit extensive cell death when the other
two are absent. Therefore, each can function in parallel
to trigger apoptosis and does not require the functions
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of the other two. However, combinatorial requirements
and selective constraints are likely to specify patterns of
PCD in development (Zhou et al. 1997). For instance,
during early embryogenesis, prior to the onset of normal
PCD, expression of grim is sufficient to elicit apoptosis,
whereas reaper is not (Chen et al. 1996b). Candidates
for regulators of signaling include members of the in-
hibitors of apoptosis (IAP) gene family. These proteins
occur in baculovirus, mammals, andDrosophila and can
modulate apoptosis in a number of contexts, including
reaper-, grim-, and hid-induced cell killing (Hay et al.
1995; Vucic et al. 1997a). As in mammalian systems,
multiple activators in the fly can function independently
through parallel circuits that ultimately converge on a
common set of effectors. Moreover, these circuits can
function coordinately and may be subject to distinct sets
of inhibitors.
Inhibitors of Cell Death
IAPs
The IAP proteins were first identified as virally en-
coded modulators of apoptosis (Clem and Miller 1994)
and later as endogenous IAPs in mammals (Liston et al.
1996). More direct evidence that Drosophila shares sim-
ilarities to mammalian apoptosis came with the identi-
fication and cloning of two fly IAP genes (Hay et al.
1995). IAPs typically encode a RING finger motif at their
carboxy terminus and two or more baculovirus IAP re-
peats at the amino terminus. The former may constitute
a negative regulatory domain, whereas the latter motif
is essential for the antiapoptotic activity associated with
these proteins. At least one mammalian IAP, NAIP, has
thus far been implicated in the pathophysiology of a
human neurodegenerative disorder (Liston et al. 1996).
In a screen for modifiers of reaper-mediated apoptosis
in the eye, Hay and colleagues identified mutations in
the Drosophila inhibitor of apoptosis 1 (diap1). Het-
erozygous mutations at this locus enhanced the reaper
death phenotype, suggesting that IAPs inhibit activator-
induced apoptosis in a dose-dependant manner. Se-
quence analyses prompted by the discovery of diap1 led
to the identification of a related gene, diap2. Unlike
diap1, heterozygous deletions at diap2 do not enhance
reaper-mediated retinal cell death. Overexpression of
diap1 or diap2 not only suppressed normal PCD in the
eye but also prevented excessive apoptosis due to ov-
erexpression of reaper, hid (Liston et al. 1996) or grim
(P. Chen and J. M. Abrams, unpublished data).
Expression of diap1 is widespread throughout the em-
bryo and the developing eye disc, but embryos homo-
zygous for loss-of-function mutations in either diap1 or
diap2 show no obvious cell-death phenotypes, possibly
owing to extensive maternal contributions of these pro-
teins and/or functional redundancies. However, clonal
analyses in postembryonic development and in the germ
line suggest that diap1 could be required for cell survival.
The precise function of the Drosophila IAP proteins
during normal development remains obscure because,
although they exhibit potent activities in sensitized trans-
genic backgrounds, their loss-of-function effects on nor-
mal apoptosis have yet to be determined. Two important
clues shed light on IAP functions. First, the IAP proteins
directly bind to reaper and inhibit apoptosis provoked
by this activator (Vucic et al. 1997a). Second, in the
mammalian system, the X-linked IAP inhibits apoptosis
by a direct interaction with caspase-3 and caspase-7
(Deveraux et al. 1997). Taken together, these results sug-
gest that the IAPs may be involved in bridging the ac-
tivators of apoptosis with the actual cell-death machine.
p35
Baculovirus p35 is another protein that engages the
death pathways triggered by reaper, grim, or hid. Miller
and his colleagues established that this protein functions
to suppress apoptosis that would otherwise occur among
infected host cells (Clem and Miller 1994). p35 bears
no obvious similarity to known proteins, yet it is capable
of suppressing cell death in mammalian (Rabizadeh et
al. 1993) and invertebrate contexts, including apoptosis
by reaper, grim, and hid (Grether et al. 1995; Chen et
al. 1996b; Nordstrom et al. 1996; White et al. 1996).
This baculovirus protein is an irreversible inhibitor of
(and pseudosubstrate for) caspases, which are thought
to be universal and requisite effectors of apoptotic cir-
cuits throughout the animal kingdom (reviewed in Co-
hen 1997).
The Cell-Death Machine: Caspases
Cell killing induced by reaper, grim, or hid triggers
induction of proteolytic activity characteristic of mem-
bers of the caspase gene family. This activity is strikingly
similar to mammalian counterparts because extracts
from Drosophila cultures exhibit signature cleavage ac-
tivity against the human death substrate, poly-ADP-ri-
bose-polymerase, a protein that is also found in flies
(Uchida et al. 1993).
At least three members of the caspase family have been
identified thus far in Drosophila. Two of these, Dro-
sophila caspase 1 (DCP1; Song et al. 1997) and Dro-
sophila interleukin-1B-converting enzyme (drICE) (Fra-
ser and Evan 1997), are most closely related to CPP-32
and Mch2, whereas the third, DREDD (P. Chen, A. Rod-
riguez, and J. M. Abrams, unpublished data) is most
closely related to ced-3 and ich-1/nedd2. DREDD is
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unique among the Drosophila caspases because of fea-
tures found in its long prodomain and a novel residue
found at its active site. Activation of these caspases oc-
curs during reaper-, grim-, and hid-induced cell killing
(P. Chen and J. M. Abrams, unpublished data), consis-
tent with the notion that these three genes act as parallel
switches that stimulate apoptosis via a common circuit
of downstream effectors. A precise determination of the
role of these caspases during PCD will require detailed
genetic and biochemical analyses. Precedents from ge-
netic studies on dcp1 (Song et al. 1997), however, suggest
that sophisticated analyses for characterizing multiply
mutated individuals will be required because of potential
confounding effects associated with functional redun-
dancies and/or maternal contributions.
Concluding Remarks
During the past several years, apoptosis research has
witnessed spectacular growth. A general lesson to be
drawn from our knowledge thus far is that the parallels
between apoptosis in Drosophila and mammals are
striking. In both systems, the death of cells is regulated
by hormones, occurs in reproducible patterns in devel-
opment, and is associated with a characteristic cyto-
morphology. Similarly, in both systems, ectopic apop-
tosis can be observed in association with defective
development and induced by ionizing radiation. These
parallels persist at the molecular level as well. In both
systems, cell death is associated with caspase activity,
DNA degradation, and modulation by IAPs. Persuasive
evidence for evolutionary conservation of these com-
ponents argues that understanding apoptosis in Dro-
sophila will have profound relevance to human pathol-
ogies in both gene discovery and disease treatment. For
instance, Drosophila death activators, reaper, grim, and
hid, might furnish excellent tools for the discovery of
therapeutic drugs intended to induce apoptosis in dis-
eased human tissues. In addition, the fly model will con-
tinue to afford us with a valuable system in which to
identify precise determinants that initiate and amplify
cascades of caspase activity. Whereas studies in mam-
malian cells have uncovered a complex meshwork of
distinct proteolytic cascades involving 110 caspases, a
reduced complexity of caspase networks in Drosophila
may facilitate the complex task of understanding caspase
circuits at both genetic and biochemical levels. It is sim-
ilarly likely that valuable information will also be ob-
tained from studies of IAP gene function. For instance,
taking observations from insect and mammalian models
together, an attractive model might propose that IAPs
normally hold caspase activation under represssion and
that apoptosis activators provoke cell death by inacti-
vating this inhibition. The sophisticated level of genetic
tools available in Drosophila will permit direct tests of
this and other possible models.
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